alexa Editor - Olivia Belbin | Hospital de la Santa Creu | 19037

Clinical Neuropsychology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Olivia Belbin

Olivia Belbin
Olivia Belbin
Senior Associate Investigator
Hospital de la Santa Creu
Spain

Biography

In 2004, supervised by Noor Kalsheker and Kevin Morgan at the University of Nottingham, I wrote my PhD thesis on genetic risk factors for Alzheimer’s disease (AD) and published 4 first author papers. In 2008, I relocated to the group of Steve Younkin at Mayo Clinic where I continued to identify AD genetic risk factors, currently listed as 8 of the top 10 AD genes. My interest in the role of synaptic dysfunction in AD began with a senior author paper in Molecular Neurodegeneration and continued following my relocation to the group of Alberto Lleó at IIB-SantPau in 2011, where I have since developed my own research group searching for synaptic biomarkers. My extensive publications, participation in international collaborations and procurement of major project grants are evidence of my contribution to AD research, which has been recognized by top journals in my field for whom I am a frequent reviewer.

Research Interest

Study of the molecular basis for synaptic dysfunction in Alzheimer’s disease and the search for synaptic cerebrospinal fluid biomarkers, imaging, proteomic, genetic and in vitro data for translational and multimodal studies.

Global Speakers in the subject

Global Experts in the subject

Publications

Thinking non-linearly

Olivia Belbin
Editorial: J Neuropsychopharmacol Mental Health
DOI: 10.4172/2472-095X.1000e105
Top